Pulsenmore’s at-home ultrasound platform, Pulsenmore ES, has received de novo authorisation from the US Food and Drug ...

Austria, and Imperial College London, UK, have introduced a new approach that enables the detection and use of residual nerve ...

Sensor-enabled surgical tools are moving from concept to clinic, owing to advances in miniaturised sensors, flexible ...

Terumo has completed its previously announced purchase of OrganOx for nearly $1.5bn after meeting all necessary regulatory ...

Elucid has launched PlaqueIQ, an AI-based image analysis software that quantifies plaque build-up to evaluate a patient’s ...

GE HealthCare has raised its fiscal year 2025 (FY25) profit outlook to between $3.02 and $3.04 per share amid solid demand ...

The FDA has granted breakthrough device designation to Augurex’s SPINEstat 14-3-3eta Autoantibody Multiplex Immunoassay Test.

Roche has obtained CE mark approval for its fully automated immunoassay, Elecsys Dengue Ag test, intended for diagnosing ...

Boston Scientific has lifted its fiscal year 2025 (FY25) profit outlook to between $3.02 and $3.04 per share amid continued ...

EndoQuest Robotics is collaborating with NVIDIA to integrate protocols within its endoluminal robotic surgery technology as ...

Donald Trump has a longstanding fixation with tariffs. Once calling them the “greatest thing ever”, the US President believes ...

Alife Health’s AI-powered selection tool, Embryo Predict, has received the CE Mark certification in compliance with the ...